Management Committee

The Chief Executive is responsible for the day to day activities of the HPRA assisted by a Management Committee comprising all HPRA directors.

Management Committee Members

 L Nolan CEO image

Dr Lorraine Nolan, Chief Executive 

Lorraine Nolan is a chemist having completed her Ph.D. and post-doctoral research at Trinity College Dublin in transdermal drug delivery. She worked for a number of years in private industry in the area of enhancing and developing drug delivery systems, and also within the state forensic science services.

Ms Nolan joined the HPRA in 2001 and since that time has held a number of different roles at senior level within the organisation across a range of areas including inspection and authorisation of human medicines, medical devices, cosmetics and controlled substances. Prior to assuming the role of Chief Executive she was Director of Human Products Authorisation & Registration. Ms Nolan is a member of the Management Board of the European Medicines Agency. 



Rita Purcell, Deputy Chief Executive

Rita Purcell joined the Irish Medicines Board in 1996 heading up the Finance and Corporate Affairs Department. Her responsibilities include finance, legal, corporate policy, property, secretariat and international affairs. Ms Purcell also sits on the Management Board of the European Medicines Agency and is on the Council of the Pharmaceutical Society of Ireland, the regulator of pharmacies and pharmacists. Ms Purcell read law at University College Dublin and qualified as a chartered accountant with PricewaterhouseCoopers. She worked in a number of different industries before joining the Irish Medicines Board. 



Dr. J.G. Beechinor, Director of Veterinary Sciences 

Gabriel Beechinor M.V.B., M.V.M, MSc., PhD., C.Dip.A.F., M.R.C.V.S qualified as a veterinary surgeon having attained both Bachelor’s and Master’s Degrees in Veterinary Medicine from University College, Dublin. Following several years in practice, he joined the regulatory authority and having served as a Veterinary Assessor for 12 years, was appointed head of department with responsibility for marketing authorisations of veterinary medicinal products in 1999. Dr. Beechinor is a member of the Poisons Council and is alternate member of the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency having previously served as a CVMP member for 13 years. Dr. Beechinor achieved a Doctor of Philosophy degree from Trinity College Dublin in 2001 as well as a distinction in his Master’s of Science degree in Executive Leadership from the University of Ulster, Northern Ireland in 2010.

 Sinead Curran HPRA Management Committee

Ms Sinead Curran, Director of Human Products Monitoring

Sinead Curran holds a Bachelor of Science (Hons) degree from the National University of Ireland Galway and a Master Science in Pharmaceutical Medicine from Trinity College Dublin. She has worked in medicines regulation for over 17 years, in the areas of clinical development and pharmacovigilance, and has held positions in academic research and pharmaceutical organisations. Ms Curran has worked with the HPRA for over 10 years, most recently in the post of GCP/pharmacovigilance inspection manager. She assumed the post of Director of HPM in January 2020, having held the post in an interim capacity from September 2019. Sinead has acted as the Irish delegate to the EMA’s GCP and PV inspectors working group, as well as its bioequivalence sub group, and has extensive experience in the areas of pharmacovigilance and safety monitoring operations.

 Dr C Fisher cropped

Dr. Caitriona Fisher, Director of Quality, Scientific Affairs & Communications

Caitríona Fisher, BSc(Pharm), MBA, PhD, MPSI, qualified as a pharmacist in 1983 and following completion of a PhD worked in community and hospital pharmacies and as a researcher in community practice. She joined the National Drugs Advisory Board in 1988 as a pharmaceutical assessor, gaining considerable experience in scientific assessment and regulatory affairs in relation to marketing authorisations and clinical trials. Prior to her current appointment, Dr Fisher was the HPRA’s quality manager, as well as chair of the EU’s Working Party of Quality Managers and of the Pharmacovigilance Audit Facilitation Group. She is currently a board member of the Irish National Accreditation Board, a member of the EPA’s Health Advisory Committee and a member of the governing body of the new Technological University Dublin.



John Lynch, Director of Compliance
John Lynch, B.Sc (Pharm), M.Sc., M.P.S.I., is responsible for the inspection, licensing, market compliance and enforcement activities. He qualified as a pharmacist from University College Dublin in 1977 and became a member of the Pharmaceutical Society of Ireland the following year. In 1980, he graduated from Trinity College Dublin with an M.Sc. in Pharmacognosy. From 1980 to 1987, he worked with Ricesteele & Co. in product development, quality control and quality assurance. In 1987, he joined the National Drugs Advisory Board (NDAB) as a GMP / GDP inspector and, in 1996, became Director of Inspection when the IMB succeeded the NDAB. With the addition of further activities and the reorganisation of the department in 2005, his job title was changed to Director of Compliance. He is a past member of the Inspectors Working Group at the EMA and of the Committee of Officials of the Pharmaceutical Inspection Co-Operation Scheme (PIC/S).


Dr Niall MacAleenan, Director of Medical Devices

Niall MacAleenan qualified as a medical doctor at Trinity College Dublin. Niall worked in a variety of clinical and research roles across the Irish health care system. He also attained a business degree from University College Dublin.

Niall joined the HPRA in 2005 as a medical assessor for medical devices. Since that time he has held a variety of different roles at senior level within the organisation both in the area of medical devices and human medicines. In 2018, he was appointed as head of the newly established medical devices department that has responsibility for the HPRA’s market regulatory, surveillance and notified body oversight activities. Niall is a member of the EU’s Medical Device Coordination Group (MDCG) and the Executive Group of the Competent Authorities for Medical Devices (CAMD) network. At international level, Niall is a member of the Management Committee of the International Medical Device Regulators Forum (IMDRF).




Lynsey Perdisatt, Director of Human Resources and Change
Lynsey Perdisatt, B.A., PgDip (Business Studies), M.B.S. (HR Strategies), joined the HPRA in 2006. Lynsey previously held a number of roles in the private sector gaining significant experience in employee relations, industrial relations and change management. Prior to her appointment as Director of Human Resources and Change, she held the role of HR Manager in the HPRA. Leading the HR team areas of responsibility included; departmental and organisational strategic planning, workforce planning, resource management, performance management and the delivery of a range of learning, development and coaching initiatives. As Director of Human Resources and Change, Lynsey is responsible for the development and delivery of Human Resources and Change strategy, the design and implementation of HR solutions and the effective management of change projects that provide for the availability, effective use and engagement of human resources within the HPRA. Lynsey is a member of the Chartered Institute of Personnel Development and is a qualified workplace mediator and investigator of disputes and conflict.         


Grainne Power, Director of Human Products Authorisation and Registration

Grainne Power joined the HPRA in 2018 to lead the Human Products Authorisation and Registration Department. Her responsibilities include the authorisation or registration of Human Medicines together with Clinical Trials authorisation for the Irish market. Ms. Power studied Biotechnology at Dublin City University and has worked in a number of Quality leadership roles within the Irish Pharma/Biopharma manufacturing sectors over a period of 25 years before joining the HPRA.

Directors are in turn assisted by their management teams.